Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may
improve the ability to detect the extent of gliomas.
PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with
MRI-guided surgery in treating patients with high-grade glioma.